Understanding the National Drug Code (NDC)
The National Drug Code (NDC) is a unique 11-digit code assigned to each medication listed under Section 510 of the US Federal Food, Drug, and Cosmetic Act. The NDC for the drug in question, 00832-1211, is associated with Jantoven, a product of Upsher-Smith Laboratories, LLC[4].
Drug Details: Jantoven
Jantoven, with the NDC 00832-1211, is a formulation of warfarin sodium, an anticoagulant used to prevent and treat blood clots. Here are some key details about this drug:
- Labeler: Upsher-Smith Laboratories, LLC
- Trade Name: Jantoven
- Active Ingredient: Warfarin Sodium
- Dosage Form: Tablet
Market Trends and Price Projections
Current Market Scenario
The pharmaceutical market, particularly for anticoagulants like warfarin, is influenced by several factors including competition from newer anticoagulants, regulatory changes, and pricing pressures.
- Competition: The anticoagulant market has seen the rise of newer drugs such as direct oral anticoagulants (DOACs), which can impact the demand for traditional anticoagulants like warfarin. However, warfarin remains a staple due to its long history of use and cost-effectiveness[2].
Price Analysis
To analyze the price projections for Jantoven (NDC 00832-1211), we need to consider several factors:
- Historical Pricing: Prices for generic drugs like warfarin can fluctuate based on market demand, production costs, and regulatory changes. However, generic drugs generally tend to be more stable in pricing compared to brand-name drugs.
- Regulatory Impact: The 340B Drug Pricing Program, which requires manufacturers to charge a ceiling price to covered entities, can influence pricing for drugs like Jantoven. The ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure[3].
Price Projections
Given the current market trends:
- Stability in Pricing: For generic drugs like Jantoven, price increases are typically modest. According to Vizient's Pharmacy Market Outlook, generic drug prices are not expected to rise significantly, with some projections indicating minimal to no increase in the near future[2].
- Market Competition: The presence of biosimilars and generic versions of other anticoagulants may keep prices in check. Biosimilars, for instance, are expected to grow in market share, which could further stabilize or even reduce prices for some medications[2].
Example Pricing Data
While specific pricing data for NDC 00832-1211 may not be readily available, we can look at similar generic drugs for a general idea. For example, prices for generic warfarin tablets can range from $0.10 to $0.50 per unit, depending on the dosage and packaging[5].
Key Factors Influencing Price
Drug Shortages and Supply Chain
Drug shortages and supply chain disruptions can significantly impact pricing. However, for well-established generic drugs like warfarin, these issues are less common compared to newer or specialty medications[2].
Regulatory Changes
Proposed changes to the NDC format, such as the potential adoption of a 12-digit format, do not directly impact pricing but can affect how drugs are listed and tracked. This could lead to administrative costs but is unlikely to significantly influence the price of the drug itself[1].
Market Demand
The demand for anticoagulants remains steady due to their essential role in patient care. This consistent demand helps stabilize prices, as manufacturers are less likely to drastically increase prices for drugs that are widely used and have established market positions.
Conclusion
The price projections for Jantoven (NDC 00832-1211) are likely to remain stable, with minimal increases expected in the near future. Here are the key takeaways:
- Stable Pricing: Generic drugs like Jantoven tend to have stable pricing due to market competition and regulatory oversight.
- Regulatory Impact: Programs like the 340B Drug Pricing Program help keep prices in check for covered entities.
- Market Demand: Consistent demand for anticoagulants ensures that prices remain relatively stable.
Key Takeaways
- Generic Stability: Prices for generic drugs are generally more stable.
- Regulatory Oversight: Programs like the 340B Drug Pricing Program influence pricing.
- Market Demand: Steady demand for anticoagulants helps maintain stable prices.
- Competition: Presence of biosimilars and other generics keeps prices in check.
FAQs
What is the National Drug Code (NDC)?
The National Drug Code (NDC) is a unique 11-digit code assigned to each medication listed under Section 510 of the US Federal Food, Drug, and Cosmetic Act.
What is Jantoven used for?
Jantoven, with the NDC 00832-1211, is an anticoagulant used to prevent and treat blood clots.
How are prices for generic drugs like Jantoven typically affected?
Prices for generic drugs like Jantoven are generally stable due to market competition and regulatory oversight.
What is the 340B Drug Pricing Program?
The 340B Drug Pricing Program requires manufacturers to charge a ceiling price to covered entities, calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure.
Are there any significant price increases projected for anticoagulants like Jantoven?
No, significant price increases are not projected for anticoagulants like Jantoven in the near future.
Sources
- FDA Drug Topics Webinar - National Drug Code (NDC) for Healthcare Providers[1].
- Vizient, Inc. - Pharmacy Market Outlook[2].
- HRSA - NDC Product Details - 340B OPAIS[3].
- FindACode - Upsher-Smith Laboratories, LLC - List of Drugs - NDC Labeler[4].
- DrugPatentWatch - Latest drug prices and trends for NDC 51672-1387[5].
